- Home
- IMVT vs STNG Comparison
IMVT vs STNG Comparison
Compare IMVT & STNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMVT
- STNG
- Stock Information
- Founded
- IMVT 2018
- STNG 2009
- Country
- IMVT United States
- STNG Monaco
- Employees
- IMVT N/A
- STNG N/A
- Industry
- IMVT Biotechnology: Biological Products (No Diagnostic Substances)
- STNG Marine Transportation
- Sector
- IMVT Health Care
- STNG Consumer Discretionary
- Exchange
- IMVT Nasdaq
- STNG Nasdaq
- Market Cap
- IMVT 2.7B
- STNG 2.2B
- IPO Year
- IMVT N/A
- STNG 2010
- Fundamental
- Price
- IMVT $15.24
- STNG $48.97
- Analyst Decision
- IMVT Buy
- STNG Buy
- Analyst Count
- IMVT 11
- STNG 4
- Target Price
- IMVT $35.88
- STNG $60.50
- AVG Volume (30 Days)
- IMVT 1.2M
- STNG 1.0M
- Earning Date
- IMVT 08-11-2025
- STNG 07-30-2025
- Dividend Yield
- IMVT N/A
- STNG 3.31%
- EPS Growth
- IMVT N/A
- STNG N/A
- EPS
- IMVT N/A
- STNG 7.37
- Revenue
- IMVT N/A
- STNG $916,164,000.00
- Revenue This Year
- IMVT N/A
- STNG N/A
- Revenue Next Year
- IMVT N/A
- STNG $2.56
- P/E Ratio
- IMVT N/A
- STNG $6.56
- Revenue Growth
- IMVT N/A
- STNG N/A
- 52 Week Low
- IMVT $12.72
- STNG $30.63
- 52 Week High
- IMVT $34.47
- STNG $74.67
- Technical
- Relative Strength Index (RSI)
- IMVT 43.58
- STNG 63.92
- Support Level
- IMVT $14.50
- STNG $44.38
- Resistance Level
- IMVT $15.52
- STNG $47.14
- Average True Range (ATR)
- IMVT 0.69
- STNG 1.57
- MACD
- IMVT -0.06
- STNG 0.15
- Stochastic Oscillator
- IMVT 41.16
- STNG 91.70
About IMVT Immunovant Inc.
Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The company operates in a single operating segment, which includes all activities related to the research, development and manufacturing of its product candidates.
About STNG Scorpio Tankers Inc.
Scorpio Tankers Inc is a provider of marine transportation of petroleum products. It owned, lease financed, or chartered in vessels spanning three different vessel segments Handymax, MR, and LR2. The company's fleet of tankers is the eco-friendly, and newest fleet on the water hauling clean petroleum products. It provides seaborne transportation of crude oil and refined petroleum products. The company generates the majority of its revenue from LR2.